Wockhardt Limited (NSE:WOCKPHARMA)
1,486.70
+21.00 (1.43%)
Jan 7, 2026, 11:50 AM IST
Wockhardt Market Cap
Wockhardt has a market cap or net worth of 238.16 billion as of January 6, 2026. Its market cap has decreased by -1.09% in one year.
Market Cap
238.16B
Enterprise Value
256.03B
Revenue
30.07B
Ranking
n/a
PE Ratio
n/a
Stock Price
1,486.70
Market Cap Chart
Since February 21, 2001, Wockhardt's market cap has increased from 17.40B to 238.16B, an increase of 1,268.47%. That is a compound annual growth rate of 11.08%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 5, 2026 | 236.00B | 0.43% |
| Dec 31, 2025 | 235.00B | 2.08% |
| Dec 31, 2024 | 230.20B | 276.45% |
| Dec 29, 2023 | 61.15B | 90.30% |
| Dec 30, 2022 | 32.13B | -29.77% |
| Dec 31, 2021 | 45.75B | -24.44% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sun Pharmaceutical Industries | 4.15T |
| Divi's Laboratories | 1.69T |
| Cipla | 1.23T |
| Apollo Hospitals Enterprise | 1.02T |
| Zydus Lifesciences | 927.70B |
| Mankind Pharma | 906.11B |
| Aurobindo Pharma | 701.26B |
| Fortis Healthcare | 691.13B |